Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
作者： Amie Franklin , John Rothman , William J. Garner
DOI:
关键词: Prodrug 、 Bisantrene 、 Pharmacology 、 Medicine
摘要: The present invention describes methods and compositions for improving the therapeutic efficacy of agents previously limited by suboptimal performance either as monotherapy or reducing side effects. Such are particularly applicable to bisantrene derivatives, analogs, prodrugs thereof.
lens.org 参考文章(315)
Angelika M. Burger, Telomere targeting agents as stem cells directed treatments ,(2008)
Jeanne Grace Flandez, Jason Gary Sagert, Daniel R. Hostetter, Olga Vasiljeva, Margaret Thy Luu Nguyen, James William West, Stephen James Moore, Activatable Antibodies that Bind Interleukin-6 Receptor and Methods of Use Thereof ,(2013)
Sonya Zabludoff, Jennifer Brown, Methods for the treatment of hematologic malignancies ,(2008)
Dirk A. Heerding, Igor Safonov, Tammy J. Clark, Jack Dale Leber, Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors ,(2007)
Michael C. Pirrung, Substituted macrocyclic compounds having proteasome inhibitory activity ,(2013)
Chengzhi Zhang, Quinoline inhibitors of tyrosine kinase ,(2011)
Xueheng Cheng, Novel derivatives of erlotinib ,(2011)
Hyun You, Yong-Chul Kim, Hyo Jin Ko, PHEOPHORBIDE-alpha CONJUGATES AND THEIR USES ,(2012)
Chun Li, Qizhen Cao, Chiyi Xiong, Anil Sood, Epherin receptor targeting agents ,(2013)
C. Anthony Altar, Gerald A. Higgins, Novel Pharmacogene Single Nucleotide Polymorphisms and Methods of Detecting Same ,(2013)